BioSpace News Archive

Drug Development

Astex and Otsuka Announce Results of the Phase 3 ASCERTAIN Study of the Novel Oral Cedazuridine/Decitabine Fixed-Dose Combination (ASTX727) in Patients with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Astex Pharmaceuticals, Inc. announce top-line results from the ASCERTAIN phase 3 study evaluating cedazuridine and decitabine fixed-dose combination (ASTX727) vs decitabine IV in adults with intermediate and high-risk MDS or CMML.

June 6, 2019
·
8 min read
Policy

Liberty Health Sciences To Introduce Zentient As New House Brand Along With All-Natural Line of Pretty Pistil Products -June 6, 2019

Liberty Health Sciences Inc announced that it will be introducing Zentient to all of its dispensaries as its new house brand of products along with a Pretty Pistil, subject to the Florida Department of Health approval.

June 6, 2019
·
4 min read
Policy

Liberty Health Sciences To Introduce Zentient As New House Brand Along With All-Natural Line of Pretty Pistil Products

Liberty Health Sciences Inc. announced that it will be introducing Zentient to all of its dispensaries as its new house brand of products along with a Pretty Pistil, subject to the Florida Department of Health approval.

June 6, 2019
·
4 min read
Business

Tergus Pharma Announces New Commercial Manufacturing Facility and Partnership with Great Point Partners

Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, today has announced a 100,000-square-foot building for its new headquarters and plans to invest to expand into commercial manufacturing.

June 6, 2019
·
3 min read
Amsterdam University Medical Center wins MR Solutions’ newly launched Image of the Year Award

The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular research image. Preclinical image submissions came in from most of MR Solutions’ users across the world.

June 6, 2019
·
2 min read
Deals

Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.

Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it has closed the previously announced acquisition of CytoSen Therapeutics, Inc. (“CytoSen”).

June 6, 2019
·
5 min read
New blood test predicts breast cancer’s return at start of treatment

A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment.

June 6, 2019
·
5 min read
Business

BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes

Agendia, Inc., a world leader in precision oncology, today announced the presentation of study results for BluePrint and MammaPrint use in identifying African-American women with hormone receptor positive tumors that have different genomic subtypes and risk than Caucasian women

June 6, 2019
·
4 min read
Drug Development

Purdue Pharma Announces First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspected Opioid Overdose

Purdue Pharma L.P. today announced the initiation and first participant enrollment in a Phase 1 clinical study that will examine pharmacokinetic properties of nalmefene hydrochloride (HCl).

June 6, 2019
·
5 min read
Genetown

Capsule Technologies, Inc. Earns MedTech Breakthrough Award

Capsule Technologies Inc., a leader in medical device integration, clinical surveillance, and non-critical care patient monitoring solutions was awarded “Best Overall Medical Data Solution Provider” by MedTech Breakthrough,

June 6, 2019
·
3 min read